# Gabapentin to Treat Itch in Patients With Liver Disease

> **NCT00058890** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 15 (actual)

## Conditions studied

- Liver Disease
- Cholestasis
- Cirrhosis
- Pruritus
- Itching

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00058890
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058890, "Gabapentin to Treat Itch in Patients With Liver Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00058890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*